Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

ONO PHARMACEUTICAL CO., LTD.

(4528)
OverzichtGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningen 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ONO PHARMACEUTICAL CO., LTD.
26/11R & D - ONO Receives Approval of Opdivo (nivolumab) for Expanded Use for Two Indication..
15/11ONO Announces the Settlement of Litigation Raised by Dr. Honjo
09/11Ono Pharmaceutical Co. - Velexbru Tablet 80 mg, a BTK inhibitor, Approved in South Kore..
09/11Nuevas compras en la cartera Inversor Asia
09/11New purchases in the Asia Investor portfolio
09/11Nouveaux achats dans le portefeuille Investisseur Asie
28/10ONO Submits an Application of ONOACT for Intravenous Infusion 50mg/150mg
14/10Caris Life Sciences and Ono Pharmaceutical Announces Strategic Collaboration Leveraging..
26/08Exelixis Announces Partner Takeda and Ono Receive Approval in Japan for CABOMETYX (cabo..
25/08EXELIXIS : Partner Takeda Secures Cabometyx Combo Nod in Japan for Metastatic Renal Cell C..
30/07ONO PHARMACEUTICAL : Corporate Governance Report
30/07Ono Pharmaceutical Co., Ltd. Provides Earnings Forecast for the Year 2021
30/07Ono Pharmaceutical Co., Ltd. Plan to Pay an Interim and Year-End Dividend
10/06Japanese shares rise, Eisai drops after 2 days of limit-up gains
02/06NIKKEI 225 : Borsa Tokyo chiude in rialzo, speranze riapertura spingono titoli turismo, im..
02/06Japan shares rally as reopening hopes boosts travel, real estate firms
02/06Japan shares rally as reopening hopes boosts travel, real estate firms
24/05Rehab for JAPAN Co., Ltd. announced that it has received •700 million in funding from a..
28/04ONO PHARMACEUTICAL : Announcement of New Office Establishment of U.S. Subsidiary (ONO PHAR..
22/04ONO PHARMACEUTICAL : Helsinn Announces the Launch of Adlumiz (anamorelin) for the Treatmen..
15/04ONO PHARMACEUTICAL : Submits Supplemental Application for Approval for Opdivo (Nivolumab) ..
09/04ONO PHARMACEUTICAL : Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy a..
05/04Ono Pharmaceutical Co., Ltd. Announces Board and Executive Changes
05/04ONO PHARMACEUTICAL : Announcement on Changes of Members of the Board of Directors, Audit &..
31/03BRISTOL MYERS SQUIBB : Ono Pharmaceutical Co., Ltd - European Medicines Agency Validates B..
29/03ONO PHARMACEUTICAL : Joins the University of California Drug Discovery Consortium
29/03ONO PHARMACEUTICAL : Received 'Osaka Governor's Award' of the Osaka Stop Global Warming Aw..
24/03ONO PHARMACEUTICAL : and Seikagaku Announce a Manufacturing and Marketing Approval in Japa..
02/03ONO PHARMACEUTICAL : Entered License Agreement with PeptiDream Inc. on Automated Peptide D..
01/03ONO PHARMACEUTICAL : Entered Sponsorship Agreements with LabCentral and MBC BioLabs
19/02ONO PHARMACEUTICAL : Submits Supplemental Application for Approval for Opdivo to Expand th..
18/02ONO PHARMACEUTICAL : Statement concerning Prosecution of Employees
09/02ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts for Priority Review Applica..
03/02ONO PHARMACEUTICAL : enters into License Agreement with Ribon Therapeutics for the Develop..
01/02ONO PHARMACEUTICAL : Announces Transfer of the Manufacturing and Marketing Approval Author..
01/02ONO PHARMACEUTICAL : Notice concerning the Establishment of Ono Pharma Healthcare Co., Ltd..
29/01ONO PHARMACEUTICAL : Statement concerning Arrest of Employees
29/01ONO PHARMACEUTICAL : Submits Supplemental Application for Approval of Opdivo to Expand the..
25/01ONO PHARMACEUTICAL : Helsinn Group - ONO Receives a Manufacturing and Marketing Approval o..
22/01ONO Receives a Manufacturing and Marketing Approval of Adlumiz, a Ghrelin Receptor Agon..
13/01ONO PHARMACEUTICAL : Notice on the Adopter of the 'Osamu Hayaishi Memorial Scholarship for..
2020ONO PHARMACEUTICAL : Enters into Exclusive License Agreement with Chordia Therapeutics on ..
2020ONO PHARMACEUTICAL : Submits Supplemental Application for Approval for Opdivo to Expand th..
2020Fate Therapeutics, Inc. and Ono Pharmaceutical Co., Ltd. Enters into A Letter Agreement
2020BRISTOL MYERS SQUIBB : Ono Pharmaceutical - Combination Therapy concerning Opdivo and Yerv..
2020ONO PHARMACEUTICAL : Receives Approval of BRAFTOVI Capsule, a BRAF Inhibitor and MEKTOVI T..
2020BRISTOL MYERS SQUIBB : Receives European Commission Approval for Opdivo as Second-Line Tre..
2020ONO PHARMACEUTICAL : Selected for the First Time for DJSI World Index and DJSI Asia Pacifi..
2020ONO PHARMACEUTICAL : FOIPAN Tablets, a Protease Enzyme Inhibitor, Started Clinical Study i..
2020Licensing, ONO and Bristol Myers Squibb Enter Patent License Agreement with Roche
2020ONO PHARMACEUTICAL : and BMSKK Submit Supplemental Applications for Opdivo and Yervoy in C..
2020Ono and Takeda Submit Supplemental Application for Opdivo and CABOMETYX Combination The..
2020Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMETYX in Comb..
2020RAFAEL : A New Phase 1 Study Began to Evaluate Rafael Pharmaceuticals Lead Compound CPI-61..
2020Ono Pharmaceutical Co., Ltd. Begins a Phase 1 Study in Japan for Patients with Pancreat..
2020Ono Enters into License Agreement on Cenobamate, an Antiepileptic Drug with SK Biopharm..
2020SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in J..
2020SK Biopharmaceuticals and Ono Pharmaceutical Enter Licensing Agreement for Cenobamate i..
2020Borsa Tokyo riparte dopo stop tecnico, Nikkei in calo su notizia Trump positivo a Covid
2020As outage ends, Nikkei plunges after Trump catches coronavirus
2020ONO PHARMACEUTICAL : To Whom Do Joint Research Results Belong? Current Situation And Issue..
2020ONO PHARMACEUTICAL : Phase III Study Result Evaluating Opdivo in Combination with Bevacizu..
2020ONO PHARMACEUTICAL : Phase II / III Study Result Evaluating Opdivo in Combination with Che..
2020Xenoma, Inc. announced that it has received funding from EPS Holdings, Inc., Ono Pharma..
2020ONO PHARMACEUTICAL : Launch of Ongentys Tablets 25mg, a Peripheral COMT Inhibitor in Japan
2020AGC Biologics Enters into Partnership with Ono Pharmaceuticals Co., Ltd. to Manufacture..
2020ONO PHARMACEUTICAL : Federal Circuit Finds Significant Contributions For Co-Inventorship
2020ONO PHARMACEUTICAL : Development of Therapeutic Drugs for Novel Coronavirus Infection
2020THEN YOU DIDN'T SEE THEM; NOW YOU DO : Co-Inventors Added
2020ONO PHARMACEUTICAL : Independently Performed, Publicly Disclosed Prior Work Can Lead To Jo..
2020ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize Winner's C..
2020ONO PHARMACEUTICAL : Federal Circuit Confirms Joint Inventorship On Nobel Prize Winner's C..
2020ONO PHARMACEUTICAL : Federal Circuit Confirms Addition Of Two Inventors Of Groundbreaking ..
2020ONO PHARMACEUTICAL : Selected for 'MSCI Japan ESG Select Leaders Index' for the 2nd consec..
2020ONO PHARMACEUTICAL : Support for Relief Efforts to the Disaster Caused by Heavy Rain in Ju..
1  2  3  4  5  6  7Volgende
Volgende evenement op ONO PHARMACEUTICAL CO., LTD.
04/02/22